MACOM Technology Solns 주식 (NASDAQ: MTSI)

에 대한 최신 뉴스 MACOM Technology Solns (NASDAQ:MTSI) 주식

MACOM TECHNOLOGY SOLUTIONS H

MACOM Technology Solns

MACOM Technology Solutions Holdings Inc is a provider of analog, digital, and mixed-signal semiconductor solutions to original equipment manufacturers and distributors. These solutions are found in systems for industrial, medical, scientific, and test and measurement markets. The firm's portfolio of products includes integrated circuits, multichip modules, power pallets and transistors, diodes, amplifiers, switches and switch limiters, passive and active components, and complete subsystems. Roughly a third of the firm's revenue is generated in the United States, with the rest coming from China, Japan, Singapore, South Korea, and other countries across the world.

MACOM Technology

What Happened

Equities

Government

Market Summary

News

Politics

Economics

Markets

Tech

General

AMKR

COHR

ENTG

INFN

INTC

MCHP

MTSI

POLA

RKLB

SKYT

WOLF

화요일(4일) 저녁 의회 합동 연설에서 도널드 트럼프 대통령은 미국에 시설을 설립하는 반도체 회사에 제조 인센티브를 제공하는 칩스법(CHIPS)의 폐지를 촉구했다. 

칩스법 폐지 시사한 트럼프...어떤 기업이 보조금 수혜 받았나?

MACOM Technology Solutions Holdings, Inc. - Common Stock

MACOM Technology Solutions Holdings Inc

On Tuesday, Bank of America Securities (BofA) analyst Vivek Arya highlighted five small and mid-cap (SMid Cap) stocks within his coverage, projecting they could outperform the SOX index over the next year. Notably, the SOX has already seen a strong 5% year-to-date gain compared to the S&amp;P 500&#8217;s 2%.
These selected companies, including Allegro MicroSystems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALGM#NASDAQ">ALGM</a>), Credo Technology Group Holding Ltd.(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRDO#NASDAQ">CRDO</a>), Nova Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVMI#NASDAQ">NVMI</a>), Coherent Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COHR#NYSE">COHR</a>), and MACOM Technology Solutions Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTSI#NASDAQ">MTSI</a>), are strategically positioned within the sector&#8217;s most investable themes.
Arya noted these companies are at the forefront of the sector&#8217;s most investable themes, exhibiting high growth or capturing market share within large, attractive total addressable markets (TAMs). He added that they&#8217;re also boosting EPS leverage through expanding margins.
Also Read: <a href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/06/45909439/nvidia-stock-could-get-boost-from-1-5-trillion-european-ai-build-out-analyst-says-significant-upside-in-shares">Nvidia Stock Could Get Boost From $1.5 Trillion European AI Build-Out: Analyst Says &#8216;Significant Upside In Shares&#8217;</a>
Among these top picks, BofA has raised price forecasts for two companies.
<h2 class="wp-block-heading">MACOM Technology Solutions Holdings</h2>
Arya increased his price forecast for MTSI to $160 (up from $140). He justified this revision with a higher 39x forward price-to-earnings (P/E) multiple for the calendar year 2026 (previously 34x), citing strong momentum in AI and defense sectors.
<h2 class="wp-block-heading">Nova Ltd.</h2>
He also raised his price forecast for NVMI to $270 from $250. This revised forecast is based on a higher 29x calendar 2026 estimated price-to-earnings (P/E) multiple (up from 26x), driven by robust demand for leading-edge Wafer Fabrication Equipment (WFE).
<h2 class="wp-block-heading">Allegro MicroSystems, Inc.</h2>
Among the other featured SMid Cap picks, ALGM, a magnetic sensor leader, is poised for a significant cyclical upturn. As noted in BofA&#8217;s June 16 initiation report, key drivers include auto sales returning to year-over-year growth in the June quarter following significant under-shipment relative to demand in the sensor category.
The content-rich e-mobility mix within auto sales is also expected to expand to the high 50% range by the second half of 2025 (from low-50%), and gross margins are projected to recover to 50% by the first half of 2026 (currently ~45.6%), with a full long-term recovery to 58% driven by increased volumes.
Coupled with disciplined operational expenditure, BofA forecasts a 46% calendar year 2024-2027 pro forma EPS Compound Annual Growth Rate (CAGR), more than three times the semiconductor peer average, justifying a premium P/E.
<h2 class="wp-block-heading">Credo Technology Group Holding Ltd.</h2>
CRDO is highlighted as a key Active Electrical Cables (AEC) supplier enabling larger AI clusters. Arya particularly favors Credo&#8217;s leadership in the fast-growing AEC market, where the TAM could double over the next two years.
He pointed to two new hyperscaler ramps scheduled for the fiscal second half of 2026, which will complement three existing customers and help reduce customer concentration.
Credo&#8217;s product portfolio is also meaningfully expanding in calendar 2026 to encompass Digital Signal Processors (DSPs), PCIe offerings, and line cards. A potential +67% EPS CAGR from calendar 2024-2027 is expected as opex growth remains below 50% of sales growth while GMs remain resilient.
<h2 class="wp-block-heading">Coherent Corp.</h2>
Finally, Coherent Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COHR#NYSE">COHR</a>), with its broad optics portfolio, is seen as playing a critical role in AI trends. Despite a wide year-to-date performance spread with Lumentum Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LITE#NASDAQ">LITE</a>) (+6% YTD vs. COHR -15% YTD), Arya maintains a Buy rating on Coherent.
This is due to its leadership across Electro-absorption Modulated Laser, Vertical Cavity Surface Emitting Laser, and Silicon Photonics technologies, which bolster its positioning for upcoming 1.6T ramps and share gains within a $32 billion data center serviceable addressable market.
Cost reductions and restructuring efforts are anticipated to drive gross margins to over 42% long-term from the current high-30s. Furthermore, U.S. fab investments could increase Indium Phosphide capacity four to five times, providing a significant competitive advantage.
Arya estimates Coherent&#8217;s long-term EPS power to be between $7.9 and $9.8, approximately 50% above Street estimates for fiscal 2028, where the implied valuation is only ~10x P/E, remaining below its ~15x historical median P/E.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/economic-data/25/06/46077396/powell-interest-rates-trump-inflation-tariffs">Will The Fed Cut Rates In 2025? Powell Says It All Depends On Tariffs</a></li>
</ul>
Photo via: Shutterstock

Analyst Color

Analyst Ratings

Trading Ideas

ALGM

CRDO

LITE

NVMI

Which Small And Mid-Cap Chip Stocks Are Set For Big Gains?

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul class="wp-block-list">
<li>Goldman Sachs lowered Advance Auto Parts, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AAP#NYSE">AAP</a>) price target from $48 to $46. Goldman Sachs analyst Kate McShane downgraded the stock from Neutral to Sell. Advance Auto Parts shares closed at $51.93 on Monday. See how other analysts <a href="https://www.benzinga.com/quote/AAP/analyst-ratings">view this stock</a>.</li>
<li>Guggenheim increased the price target for Cidara Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDTX#NASDAQ">CDTX</a>) from $50 to $68. Guggenheim analyst Seamus Fernandez maintained a Buy rating. Cidara Therapeutics shares closed at $44.95 on Monday. <a href="https://www.benzinga.com/quote/CDTX/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Needham raised CorMedix Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRMD#NASDAQ">CRMD</a>) price target from $15 to $20. Needham analyst Serge Belanger maintained a Buy rating. CorMedix shares closed at $16.56 on Monday. See how other analysts <a href="https://www.benzinga.com/quote/CRMD/analyst-ratings">view this stock</a>.</li>
<li>HC Wainwright &amp; Co. boosted the price target for Lyell Immunopharma Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYEL#NASDAQ">LYEL</a>) from $1 to $10. HC Wainwright &amp; Co. analyst Mitchell Kapoor maintained a Neutral rating. Lyell Immunopharma shares closed at $8.99 on Monday. <a href="https://www.benzinga.com/quote/LYEL/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Goldman Sachs slashed the price target for RH (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RH#NYSE">RH</a>) from $199 to $179. Goldman Sachs analyst Kate McShane downgraded the stock from Neutral to Sell. RH shares closed at $186.22 on Monday. <a href="https://www.benzinga.com/quote/RH/analyst-ratings">See how other analysts view this stock.</a></li>
<li>B of A Securities cut DICK&#8217;S Sporting Goods Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DKS#NYSE">DKS</a>) price target from $250 to $240. B of A Securities analyst Robert Ohmes maintained a Buy rating. DICK&#8217;S Sporting shares settled at $175.79 on Monday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>B of A Securities raised MACOM Technology Solutions Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTSI#NASDAQ">MTSI</a>) price target from $250 to $270. B of A Securities analyst Vivek Arya maintained a Buy rating. MACOM Technology Solutions shares closed at $138.65 on Monday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Keybanc increased Westinghouse Air Brake Technologies Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WAB#NYSE">WAB</a>) price target from $220 to $240. Keybanc analyst Steve Barger maintained an Overweight rating. Westinghouse Air Brake Technologies shares closed at $202.19 on Monday.  <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Cantor Fitzgerald raised the price target for Applied Materials, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMAT#NASDAQ">AMAT</a>) from $200 to $220. Cantor Fitzgerald analyst Matthew Prisco maintained an Overweight rating. Applied Materials shares settled at $171.96 on Monday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Cantor Fitzgerald increased Lam Research Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LRCX#NASDAQ">LRCX</a>) price target from $90 to $115. Cantor Fitzgerald analyst Matthew Prisco maintained an Overweight rating. Lam Research shares closed at $91.61 on Monday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Considering buying AAP stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="554" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/24084704/image-361-1024x554.png" alt="" class="wp-image-959828" style="width:540px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/24084704/image-361-1024x554.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/24084704/image-361-300x162.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/24084704/image-361-768x415.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/24084704/image-361.png 1132w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-stock-ratings/price-target/25/06/46067537/blackberry-gears-up-for-q1-print-here-are-the-recent-forecast-changes-from-wall-streets-most-accurate-analysts">BlackBerry Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street&#8217;s Most Accurate Analysts</a></li>
</ul>
Photo via Shutterstock

Price Target

AMAT

CDTX

CRMD

CTVA

LRCX

LYEL

Applied Materials To Rally Around 28%? Here Are 10 Top Analyst Forecasts For Tuesday

7 analysts have expressed a variety of opinions on MACOM Technology Solns (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTSI#NASDAQ">MTSI</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">5</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $138.57, a high estimate of $160.00, and a low estimate of $120.00. Highlighting a 7.11% decrease, the current average has fallen from the previous average price target of $149.17. 
<img src="https://www.benzinga.com/files/images/story/2025/1750770066_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
A clear picture of MACOM Technology Solns's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Vivek Arya</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$160.00</td>
<td>$140.00</td>
</tr>
<tr>
<td>Tom O'Malley</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$150.00</td>
<td>$125.00</td>
</tr>
<tr>
<td>David Williams</td>
<td>Benchmark</td>
<td>Maintains</td>
<td>Buy</td>
<td>$160.00</td>
<td>$160.00</td>
</tr>
<tr>
<td>Tom O'Malley</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$125.00</td>
<td>$160.00</td>
</tr>
<tr>
<td>Tore Svanberg</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Buy</td>
<td>$120.00</td>
<td>$150.00</td>
</tr>
<tr>
<td>Vivek Arya</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$130.00</td>
<td>$160.00</td>
</tr>
<tr>
<td>William Stein</td>
<td>Truist Securities</td>
<td>Announces</td>
<td>Buy</td>
<td>$125.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to MACOM Technology Solns. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of MACOM Technology Solns compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of MACOM Technology Solns's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of MACOM Technology Solns's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/MTSI/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on MACOM Technology Solns analyst ratings.</a>
<h2>All You Need to Know About MACOM Technology Solns</h2>
MACOM Technology Solutions Holdings Inc is a provider of analog, digital, and mixed-signal semiconductor solutions to original equipment manufacturers and distributors. These solutions are found in systems for industrial, medical, scientific, and test and measurement markets. The firm's portfolio of products includes integrated circuits, multichip modules, power pallets and transistors, diodes, amplifiers, switches and switch limiters, passive and active components, and complete subsystems. Roughly a third of the firm's revenue is generated in the United States, with the rest coming from China, Japan, Singapore, South Korea, and other countries across the world.
<h3>Financial Milestones: MACOM Technology Solns's Journey</h3>
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Growth: MACOM Technology Solns's remarkable performance in 3M is evident. As of 31 March, 2025, the company achieved an impressive revenue growth rate of 30.16%. This signifies a substantial increase in the company's top-line earnings. When compared to others in the Information Technology sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: MACOM Technology Solns's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of 13.42%, the company may face hurdles in effective cost management.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of 2.69%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): MACOM Technology Solns's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of 1.68%, the company may face hurdles in achieving optimal financial performance.
Debt Management: MACOM Technology Solns's debt-to-equity ratio stands notably higher than the industry average, reaching 0.44. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
<h2>The Significance of Analyst Ratings Explained</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

A Glimpse Into The Expert Outlook On MACOM Technology Solns Through 7 Analysts

B of A Securities analyst Vivek Arya maintains MACOM Technology Solns (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTSI#NASDAQ">MTSI</a>) with a Buy and raises the price target from $140 to $160.

B of A Securities Maintains Buy on MACOM Technology Solns, Raises Price Target to $160

WIIM

ACLS

ACMR

ALAB

AMBA

AOSL

ATOM

AXTI

BZAI

CEVA

CRUS

CSIQ

DIOD

FORM

FSLR

GCTS

HIMX

ICHR

INDI

KLIC

Maxeon Solar Technologies, Ltd. - Ordinary Shares

MAXN

MKSI

MOBX

MPWR

NVTS

OLED

Penguin Solutions, Inc. - Ordinary Shares

PENG

POWI

QRVO

RGTI

SITM

SLAB

SMTC

SWKS

SYNA

UCTT

VECO

Shares of semiconductor companies are higher after the US and China agreed to a temporary reduction in most tariffs on each other's goods. A reduction in tariffs could alleviate some supply chain concerns and improve macro sentiment as well as demand visibility.

Barclays analyst Tom O'Malley maintains MACOM Technology Solns (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTSI#NASDAQ">MTSI</a>) with a Overweight and raises the price target from $125 to $150.

Barclays Maintains Overweight on MACOM Technology Solns, Raises Price Target to $150

Benchmark analyst David Williams reiterates MACOM Technology Solns (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTSI#NASDAQ">MTSI</a>) with a Buy and maintains $160 price target.

Reiteration

Benchmark Reiterates Buy on MACOM Technology Solns, Maintains $160 Price Target

MACOM Technology Solutions shares are trading higher after the company reported better-than-expected Q2 financial results and issued Q3 sales guidance above estimates.

MACOM Technology Solns (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTSI#NASDAQ">MTSI</a>) is looking for Q3 Adj EPS of $0.87-$0.91 vs $0.88 analyst estimate. sees sales of $246.000 million-$254.000 million vs $237.20 million analyst estimate.

Guidance

MACOM Technology Solns Sees Q3 Adj EPS $0.87-$0.91 vs $0.88 Est; Sees Sales $246.000M-$254.000M vs $237.20M Est

MACOM Technology Solns (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTSI#NASDAQ">MTSI</a>) reported quarterly earnings of $0.85 per share which beat the analyst consensus estimate of $0.84 by 1.19 percent. This is a 44.07 percent increase over earnings of $0.59 per share from the same period last year. The company reported quarterly sales of $235.89 million which beat the analyst consensus estimate of $229.51 million by 2.78 percent. This is a 30.16 percent increase over sales of $181.23 million the same period last year.

Earnings

Earnings Beats

MACOM Technology Solns Q2 Adj. EPS $0.85 Beats $0.84 Estimate, Sales $235.89M Beat $229.51M Estimate

AAOI

ABCL

ABEV

ACIC

ACIW

ACTG

AFRM

AKAM

AKBA

ALIT

ALRM

ALXO

Amplify YieldShares Oil Hedged MLP Income ETF

AMLX

AMPX

AMTX

APPN

APYX

AQMS

ARGX

ARHS

ARKO

ARLO

ASPN

ASTH

Adtalem Global Education Inc. Common Stock

ATGE

ATHM

ATUS

AUTL

AVAH

AVPT

AXGN

BAER

BBDC

BIGC

BILL

BIRD

BlackSky Technology Inc. Class A Common Stock

BKSY

BLFS

BLND

CARG

CARS

CBLL

CBUS

CCEC

CCOI

CCRD

CION

CLAR

CLFD

CLNE

CLSK

CMPS

CMRE

CODX

COIN

COLD

COLL

COMP

CRNX

CRON

CROX

CRVS

CTEV

CTKB

CTLP

CVRX

DAVE

DCGO

DCTH

DKNG

Earnings Scheduled For May 8, 2025

AVGO

COHU

KLAC

LSCC

MRVL

NVDA

NXPI

ONTO

QCOM

RMBS

SMCI

Shares of semiconductor companies are trading higher amid overall market strength due to March's strong durable goods orders economic data, and President Trump's announcement that he met with China earlier today.

AEVA

ANET

CAMT

CIEN

COMM

CRSR

DELL

DOCN

Shares of companies within the broader technology sector are trading higher amid overall market strength after President Trump said he had no intention of firing Fed Chair Powell. Additionally, Trump indicated the final tariff rate would be less than the current 145% but not 0%.

Comments

MACOM Technology Solns

뉴스

에 대한 최신 뉴스 MACOM Technology Solns (NASDAQ:MTSI) 주식

수요일, 3월 05, 2025

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌